Literature DB >> 28339817

BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.

Jo Ledingham1, Nicola Gullick2, Katherine Irving2, Rachel Gorodkin3, Melissa Aris3, Jean Burke4, Patrick Gordon2, Dimitrios Christidis5, Sarah Galloway6, Eranga Hayes7, Andrew Jeffries8, Scott Mercer9, Janice Mooney10, Sander van Leuven11, James Galloway12.   

Abstract

Keywords:  DMARDs; co-morbidity; drug toxicity; methotrexate; rheumatic disease; safe prescribing; shared care; treatment monitoring

Mesh：

Substances：

Year:  2017        PMID： 28339817     DOI： 10.1093/rheumatology/kew479

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  23 in total

Review 1.  Clinical connection between rheumatoid arthritis and liver damage.

Authors:  Biljana Radovanović-Dinić; Snežana Tešić-Rajković; Valentina Zivkovic; Saša Grgov
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

2.  Hydroxychloroquine use: the potential impact of new ocular screening guidelines.

Authors:  M Yates; R Malaiya; J Stack; J B Galloway
Journal:  Eye (Lond)       Date:  2017-08-11       Impact factor: 3.775

3.  Recommendation for the Management of Spondyloarthritis Patients in Kuwait.

Authors:  Yaser Ali; Fatemah Abutiban; Adel Alawadhi; Ali AlDei; Ahmad Alenizi; Hebah Alhajeri; Adeeba Al-Herz; Waleed Alkandari; Ahmad Dehrab; Eman Hasan; Sawsan Hayat; Aqeel Ghanem; Khulood Saleh; Xenofon Baraliakos
Journal:  Open Access Rheumatol       Date:  2020-08-12

Review 4.  Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.

Authors:  Kathleen M M Vanni; Houchen Lyu; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2020-04-01       Impact factor: 7.580

Review 5.  Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs.

Authors:  William F C Rigby; Kathy Lampl; Jason M Low; Daniel E Furst
Journal:  Int J Rheumatol       Date:  2017-10-31

Review 6.  Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

Authors:  Catherine King; Lorraine Harper
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-11-13

7.  Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome.

Authors:  George E Fragoulis; Caron Paterson; Ashley Gilmour; Mohammad H Derakhshan; Iain B McInnes; Duncan Porter; Stefan Siebert
Journal:  RMD Open       Date:  2018-10-08

8.  Comment on: BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.

Authors:  Angela Pakozdi; Hasan Tahir
Journal:  Rheumatol Adv Pract       Date:  2017-11-02

9.  Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study.

Authors:  Kenneth F Baker; Andrew J Skelton; Dennis W Lendrem; Adam Scadeng; Ben Thompson; Arthur G Pratt; John D Isaacs
Journal:  J Autoimmun       Date:  2019-07-04       Impact factor: 14.511

10.  Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error.

Authors:  Maame-Boatemaa Amissah-Arthur; Winifred Baah
Journal:  Ghana Med J       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.